Home › Research › Topics › pioglitazone
pioglitazone
4 studies tagged pioglitazone, dated 2005-04-07 to 2021-12-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease 2021-12-01
- Effect of pioglitazone medication on the incidence of dementia 2015-06-30
- Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease 2015-03-11
Studies
4 studies carry this tag.
Date range
2005 to 2021
Top journals
- Aging and disease 1
- Annals of neurology 1
- Brain : a journal of neurology 1
- Scientific reports 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Alzheimer's disease (AD) is the leading cause of dementia that has remained a major medical, sociocultural and economical challenge globally.
-
These findings indicate that pioglitazone treatment is associated with a reduced dementia risk in initially non-insulin-dependent diabetes mellitus patients.
-
Pioglitazone is currently undergoing clinical trials for treatment of Alzheimer's disease (AD).
-
Neuritic plaques in the brain of Alzheimer's disease patients are characterized by beta-amyloid deposits associated with a glia-mediated inflammatory response.